Search

Your search keyword '"Kabisch M"' showing total 174 results

Search Constraints

Start Over You searched for: Author "Kabisch M" Remove constraint Author: "Kabisch M"
174 results on '"Kabisch M"'

Search Results

1. Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium

2. A randomized, double-blind, multicenter phase II AIO trial with Gemcitabine plus Sorafenib versus Gemcitabine plus placebo in patients with chemo-naïve advanced or metastatic biliary tract cancer: first safety and efficacy data: V736

4. Genome-wide association study of germline variants and breast cancer-specific mortality

5. Genome-wide association study of germline variants and breast cancer-specific mortality

6. Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis

7. Genome-wide association study of germline variants and breast cancer-specific mortality.

8. Genome-wide association study of germline variants and breast cancer-specific mortality

9. Body mass index and breast cancer survival: a Mendelian randomization analysis

10. Body mass index and breast cancer survival:a Mendelian randomization analysis

11. Body mass index and breast cancer survival

12. TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer

13. TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer

14. rs2735383, located at a microRNA binding site in the 3'UTR of NBS1, is not associated with breast cancer risk

15. Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation

16. Evidence that the 5p12 variant rs10941679 confers susceptibility to estrogen receptor positive breast cancer through FGF10 and MRPS30 regulation

17. Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer

18. Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent

19. Genetic predisposition to ductal carcinoma in situ of the breast

20. BRCA2 polymorphic stop codon K3326X and the risk of breast, prostate, and ovarian cancers

21. Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21

22. No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing

23. Identification of novel genetic markers of breast cancer survival

24. Common germline polymorphisms\ud associated with breast cancer-specific survival

25. Large-Scale Genomic Analyses Link Reproductive Aging to Hypothalamic Signaling, Breast Cancer Susceptibility, and BRCA1-Mediated DNA Repair EDITORIAL COMMENT

26. Identification of novel genetic markers of breast cancer survival

27. Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus

28. Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21

29. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus

30. BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers

31. Genetic predisposition to ductal carcinoma in situ of the breast

32. Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation

33. Fine-mapping of the 1p11.2 breast cancer susceptibility locus

34. Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus

35. Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent

36. Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer

37. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer

38. Genetic predisposition to ductal carcinoma in situ of the breast

39. Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer

40. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus

41. Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus

42. Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer

43. No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing

44. Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent

45. Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus

46. rs2735383, located at a microRNA binding site in the 3 ' UTR of NBS1, is not associated with breast cancer risk

47. A polymorphism in the base excision repair gene PARP2 is associated with differential prognosis by chemotherapy among postmenopausal breast cancer patients

48. Identification of novel genetic markers of breast cancer survival

49. Common germline polymorphisms associated with breast cancer-specific survival

50. Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression

Catalog

Books, media, physical & digital resources